SO
70
-5
MHK
45
-7
BWA
57
-3
ITW
46
-3
THC
62
-4
TGNA
48
-8
R
70
-3
SCHW
64
-7
PHM
41
-3
FLS
61
-4
IPG
47
5
MDT
53
-7
DIS
64
-5
BMY
48
-3
QCOM
58
-5
AMT
39
-2
USB
64
-9
GT
38
-5
RHI
24
-6
CMG
43
-5
SO
70
-5
MHK
45
-7
BWA
57
-3
ITW
46
-3
THC
62
-4
TGNA
48
-8
R
70
-3
SCHW
64
-7
PHM
41
-3
FLS
61
-4
IPG
47
5
MDT
53
-7
DIS
64
-5
BMY
48
-3
QCOM
58
-5
AMT
39
-2
USB
64
-9
GT
38
-5
RHI
24
-6
CMG
43
-5
Financhill
Back

Phathom Pharmaceuticals 10K Form

Sell
25

PHAT
Phathom Pharmaceuticals

Last Price:
$4.11
Seasonality Move:
0.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PHAT News And Ratings

See the #1 stock for the next 7 days that we like better than PHAT

PHAT Financial Statistics

Sales & Book Value

Annual Sales: $55.3M
Cash Flow: $-84.9M
Price / Cash Flow: 0
Annual Sales: $-4.86
Price / Book: 0

Profitability

EPS (TTM): -5.24000
Net Income (TTM): $-345.8M
Gross Margin: $47.3M
Return on Equity: 0%
Return on Assets: -99.63%

Phathom Pharmaceuticals Earnings Forecast

Key Phathom Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 3 years for PHAT is 85.57%.
  • The Selling, General & Administrative Expenses for PHAT have been equal to 526.07% of Gross Profit Margin.
  • The Research & Development expenses have been 61.68% of Revenue.
  • The Net Earning history of PHAT is -605.09% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 2 years.

Phathom Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PHAT
CUSIP: 71722W
Website: phathompharma.com

Debt

Debt-to-Equity Ratio: -0.6
Current Ratio: 3.58
Quick Ratio: 3.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PHAT Technical Analysis vs Fundamental Analysis

Sell
25
Phathom Pharmaceuticals (PHAT) is a Sell

Is Phathom Pharmaceuticals a Buy or a Sell?